Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
Adamis Soars After Submitting Covid Drug to FDA
By Dan Weil
Jan 20, 2021 1:06 PM EST
INVESTING
Adamis Soars After Submitting Covid Drug to FDA
By Dan Weil
Jan 20, 2021 1:06 PM EST
PRESS RELEASES
Adamis Pharmaceuticals Announces IND Submission To FDA For Tempol For The Treatment Of COVID-19
By GlobeNewswire
Jan 20, 2021 9:00 AM EST
PRESS RELEASES
Adamis Pharmaceuticals Describes Planned Response To ZIMHI Complete Response Letter
By GlobeNewswire
Dec 1, 2020 9:00 AM EST
PRESS RELEASES
Adamis Pharmaceuticals Receives A Complete Response Letter From The FDA Regarding ZIMHI
By GlobeNewswire
Nov 16, 2020 6:45 AM EST
PRESS RELEASES
Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results And Business Update
By GlobeNewswire
Nov 9, 2020 4:30 PM EST
PRESS RELEASES
Adamis Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock
By GlobeNewswire
Sep 18, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces Proposed Public Offering Of Common Stock
By GlobeNewswire
Sep 17, 2020 4:05 PM EDT
PRESS RELEASES
Adamis Pharmaceuticals Provides Update On Annual Meeting Of Stockholders
By GlobeNewswire
Sep 3, 2020 4:05 PM EDT
PRESS RELEASES
Adamis Pharmaceuticals Provides Update On Annual Meeting Of Stockholders And Proposals
By GlobeNewswire
Aug 25, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Provides Update On Annual Meeting Of Stockholders
By GlobeNewswire
Aug 21, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results And Business Update
By GlobeNewswire
Aug 17, 2020 4:40 PM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces Pre-IND Feedback From FDA Enabling Advancement Of Tempol, A Novel Anti-Inflammatory And Anti-Oxidant Drug For The Treatment Of COVID-19
By GlobeNewswire
Aug 14, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Regains Compliance With NASDAQ Minimum Bid Price Requirement
By GlobeNewswire
Aug 5, 2020 4:05 PM EDT
PRESS RELEASES
Adamis Pharmaceuticals Provides Update On SYMJEPI Products
By GlobeNewswire
Jul 1, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces Publication Of Pharmacokinetic Model Suggesting That Higher Doses Of Naloxone Are Needed For Successful Resuscitation Due To Fentanyl Overdose
By GlobeNewswire
Jun 18, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces License To Commercialize Tempol, A Novel Investigational Anti-inflammatory And Antioxidant Drug For The Treatment Of Respiratory Diseases Including COVID-19
By GlobeNewswire
Jun 15, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces First Quarter 2020 Financial Results And Business Update
By GlobeNewswire
May 18, 2020 4:35 PM EDT
PRESS RELEASES
Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application To FDA
By GlobeNewswire
May 18, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Schedules First Quarter 2020 Earnings Conference Call And Business Update
By GlobeNewswire
May 15, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Provides Update On SYMJEPI Products And Announces Distribution And Commercialization Agreement For SYMJEPI And ZIMHI Products
By GlobeNewswire
May 11, 2020 8:35 PM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces Publication Demonstrating PET Scan Results Of Higher Dose Naloxone In Monkeys
By GlobeNewswire
Apr 23, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces Production Of Additional Drugs By Its US Compounding Subsidiary To Aid In The COVID-19 Pandemic
By GlobeNewswire
Apr 21, 2020 9:00 AM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces Receipt Of Loan Proceeds Under Paycheck Protection Program
By GlobeNewswire
Apr 15, 2020 4:05 PM EDT
PRESS RELEASES
Adamis Pharmaceuticals Announces Production Of Products By Its Subsidiary US Compounding To Aid In The COVID-19 Pandemic
By GlobeNewswire
Apr 1, 2020 9:00 AM EDT
